Growth Metrics

Edwards Lifesciences (EW) Change in Cash (2016 - 2026)

Edwards Lifesciences has reported Change in Cash over the past 17 years, most recently at $244.7 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 139.18% year-over-year to $244.7 million; the TTM value through Dec 2025 reached -$119.3 million, down 106.24%, while the annual FY2025 figure was -$119.3 million, 106.24% down from the prior year.
  • Change in Cash for Q4 2025 was $244.7 million at Edwards Lifesciences, up from -$595.2 million in the prior quarter.
  • Over five years, Change in Cash peaked at $2.0 billion in Q3 2024 and troughed at -$652.5 million in Q4 2021.
  • A 5-year average of $87.0 million and a median of $119.4 million in 2021 define the central range for Change in Cash.
  • Biggest five-year swings in Change in Cash: crashed 482.25% in 2021 and later surged 1905.38% in 2022.
  • Year by year, Change in Cash stood at -$652.5 million in 2021, then rose by 26.57% to -$479.1 million in 2022, then surged by 44.5% to -$265.9 million in 2023, then plummeted by 134.9% to -$624.6 million in 2024, then surged by 139.18% to $244.7 million in 2025.
  • Business Quant data shows Change in Cash for EW at $244.7 million in Q4 2025, -$595.2 million in Q3 2025, and $141.2 million in Q2 2025.